Last updated on July 2019

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)


Brief description of study

The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice

Clinical Study Identifier: NCT02078427

Find a site near you

Start Over

Hemoce - Ce

Fortaleza, Brazil
  Connect »

Hemepar - Pr

Curitiba, Brazil
  Connect »

Hemorgs - Rs

Porto Alegre, Brazil
  Connect »

Hemorio - Rj

Rio de Janeiro, Brazil
  Connect »

Rigshospitalet

Copenhagen, Denmark
  Connect »

CIC

Saint Priest en Jarez, France
  Connect »

Kantonsspital St. Gallen

St. Gallen, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Kinderspital Z rich

Zürich, Switzerland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.